COVID-19: Global radiation oncology’s targeted response for pandemic preparedness

Mukherjee, 2003, Hiding in the bunker: challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreak, Australas Radiol, 47, 143, 10.1046/j.0004-8461.2003.01165.x Gay, 2019, Lessons learned from Hurricane Maria in Puerto Rico: practical measures to mitigate the impact of a catastrophic natural disaster on radiation oncology patients, Practical Radiat Oncol, 9, 305, 10.1016/j.prro.2019.03.007 @Rad_Nation. RadOnc Journal Club - COVID19 response. 2020 17/03/2020]; Available from: https://wke.lt/w/s/cehkH6. Slotman BJ, Ricardi U, Lievens Y, Radiotherapy in a time of crisis, ESTRO Presidents' statement. 2020. Eichler, 2020 Beaver, 2017, Comparing hospital and telephone follow-up for patients treated for stage–I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial, BJOG, 124, 150, 10.1111/1471-0528.14000 Frankland, 2019, Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme, BMC Cancer, 19, 368, 10.1186/s12885-019-5561-0 Schmidt-Hansen, 2012, What is the most effective follow-up model for lung cancer patients? A systematic review, J Thoracic Oncol, 7, 821, 10.1097/JTO.0b013e31824afc55 Cusack, 2010, A literature review of the potential of telephone follow-up in colorectal cancer, J Clin Nurs, 19, 2394, 10.1111/j.1365-2702.2010.03253.x Zhou, 2012, The utilization of telephone follow-up in the advanced cancer population: a review of the literature, J Comp Eff Res, 1, 509, 10.2217/cer.12.63 Beaver, 2009, Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial, BMJ, 338, 10.1136/bmj.a3147 Kimman, 2010, Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer, BMC Cancer, 10, 174, 10.1186/1471-2407-10-174 Greenhalgh, 2020, Video consultations for covid-19, BMJ, 368 Hoskin, 2015, A multicenter randomized trial of ibandronate compared with single-dose radiotherapy for localized metastatic bone pain in prostate cancer, JNCI, 107, 10.1093/jnci/djv197 Chow, 2019, Single vs multiple fraction palliative radiation therapy for bone metastases: cumulative meta-analysis, Radiother Oncol, 141, 56, 10.1016/j.radonc.2019.06.037 Yu, 2019, Persistent use of extended fractionation palliative radiotherapy for medicare beneficiaries with metastatic breast cancer, 2011 to 2014, Am J Clin Oncol, 42, 493, 10.1097/COC.0000000000000548 Ong, 2020, Variation in the use of single-versus multifraction palliative radiation therapy for bone metastases in Australia, Int J Radiat Oncol Biol Phys, 106, 61, 10.1016/j.ijrobp.2019.08.061 Hoskin, 2019, Effect of single-fraction vs multifraction radiotherapy on ambulatory status among patients with spinal canal compression from metastatic cancer: the SCORAD randomized clinical trial, JAMA, 322, 2084, 10.1001/jama.2019.17913 Mulvenna, 2016, Lancet, 388, 2004, 10.1016/S0140-6736(16)30825-X Haviland, 2013, The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials, Lancet Oncol, 14, 1086, 10.1016/S1470-2045(13)70386-3 Brunt, 2016, Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial, Radiother Oncol, 120, 114, 10.1016/j.radonc.2016.02.027 Livi, 2015, Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial, Eur J Cancer, 51, 451, 10.1016/j.ejca.2014.12.013 Bartlett, 2017, The UK HeartSpare Study (Stage II): multicentre evaluation of a voluntary breath-hold technique in patients receiving breast radiotherapy, Clin Oncol (R Coll Radiol), 29, e51, 10.1016/j.clon.2016.11.005 Vaidya, 2010, Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial, Lancet, 376, 91, 10.1016/S0140-6736(10)60837-9 Esposito, 2018, Update on intraoperative radiotherapy: new challenges and issues, Ecancermedicalscience, 12, 793, 10.3332/ecancer.2018.793 Naoum, 2019, The impact of chest wall boost on reconstruction complications and local control in patients treated for breast cancer, Int J Radiat Oncol Biol Phys, 105, 155, 10.1016/j.ijrobp.2019.04.027 Early Breast Cancer Trialists' Collaborative, G., et al., Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst. Monographs, 2010. 2010(41): p. 162–177. Hughes, 2013, Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343, J Clin Oncol, 31, 2382, 10.1200/JCO.2012.45.2615 Matuschek, 2017, The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer - a meta-analysis of randomized trials, Radiat Oncol (London, England), 12, 60, 10.1186/s13014-017-0796-x Olivotto, 2009, Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy, J Clin Oncol, 27, 16, 10.1200/JCO.2008.18.1891 Neal, 2020, Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received, Eur Urol, 77, 320, 10.1016/j.eururo.2019.10.030 Crook, 2009, Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 73, 327, 10.1016/j.ijrobp.2008.04.075 Ghadjar, 2018, Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy, Strahlenther Onkol, 194, 619, 10.1007/s00066-018-1269-3 Dearnaley, 2014, Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, Lancet Oncol, 15, 464, 10.1016/S1470-2045(14)70040-3 Widmark, 2019, Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial, Lancet, 394, 385, 10.1016/S0140-6736(19)31131-6 Dearnaley, 2016, Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial, Lancet Oncol, 17, 1047, 10.1016/S1470-2045(16)30102-4 Brand, 2019, Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial, Lancet Oncol, 20, 1531, 10.1016/S1470-2045(19)30569-8 Parker, 2018, Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial, Lancet, 392, 2353, 10.1016/S0140-6736(18)32486-3 Salehi, 2019, Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients, AJR Am J Roentgenol, 2020, 1 Videtic, 2014, 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 90, 203, 10.1016/j.ijrobp.2014.05.017 Siva, 2019, Single fraction SBRT for early stage lung cancer; less is more?, Int J Radiat Oncol Biol Phys, 103, 1085, 10.1016/j.ijrobp.2018.12.041 World Health Organization, Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19). 2020. Ferguson, 2020 National Health Service England, COVID 19 Information Governance Advice. 2020. Filippi, 2020, COVID-19 outbreak in Northern Italy: First practical indications for radiotherapy departments, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2020.03.007 Royal College of Radiologists UK, 2019 Kunkler, 2015, Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial, Lancet Oncol, 16, 266, 10.1016/S1470-2045(14)71221-5 Bartelink, 2015, Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial, Lancet Oncol, 16, 47, 10.1016/S1470-2045(14)71156-8 Malmström, 2012, Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial, Lancet Oncol, 13, 916, 10.1016/S1470-2045(12)70265-6 Wick, 2012, Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial, Lancet Oncol, 13, 707, 10.1016/S1470-2045(12)70164-X Suzuki, 2012, Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience, Oncology, 82, 347, 10.1159/000338318 Rusthoven, 2017, Prophylactic Cranial Irradiation (PCI) versus active MRI surveillance for small cell lung cancer: the case for Equipoise, J Thoracic Oncol, 12, 1746, 10.1016/j.jtho.2017.08.016 Chauffert, 2008, Ann Oncol, 19, 1592, 10.1093/annonc/mdn281 Hamdy, 2016, 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer, N Engl J Med, 375, 1415, 10.1056/NEJMoa1606220 Willeumier, 2016, Lack of clinical evidence for postoperative radiotherapy after surgical fixation of impending or actual pathologic fractures in the long bones in patients with cancer; a systematic review, Radiother Oncol, 121, 138, 10.1016/j.radonc.2016.07.009 Chow, 2014, Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial, Lancet Oncol, 15, 164, 10.1016/S1470-2045(13)70556-4 Thirion, 2020, Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression, Br J Cancer, 10.1038/s41416-020-0768-z Borgelt, 1980, The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group, Int J Radiat Oncol Biol Phys, 6, 1, 10.1016/0360-3016(80)90195-9 Priestman, 1996, Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases, Clin Oncol, 8, 308, 10.1016/S0936-6555(05)80717-4 Deressa, 2020, Short-course 2-dimensional radiation therapy in the palliative treatment of esophageal cancer in a developing country: a Phase II study (Sharon Project), Int J Radiat Oncol Biol Phys, 106, 67, 10.1016/j.ijrobp.2019.10.004 Roa, 2015, International atomic energy agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme, J Clin Oncol, 33, 4145, 10.1200/JCO.2015.62.6606 Porceddu, 2007, Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment–“Hypo Trial”, Radiother Oncol, 85, 456, 10.1016/j.radonc.2007.10.020 Nguyen, 2015, 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers, British J Radiol, 88, 20140646, 10.1259/bjr.20140646 Jeremic, 2015, The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting, Radiother Oncol, 116, 21, 10.1016/j.radonc.2015.06.017 Rathod, 2017, Quality of life outcomes in a phase 3 Randomized trial of optimization of treatment of advanced non–small cell lung cancer using radiation therapy and chemotherapy: IAEA multicentric randomized phase 3 study (NCT00864331), Int J Radiat Oncol Biol Phys, 99, S103, 10.1016/j.ijrobp.2017.06.246 Report to the Medical Research Council by its Lung Cancer Working, P., Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. British J Cancer, 1991. 63(2): p. 265–270. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. Br J Cancer, 1992. 65(6): p. 934–41. Farina, 2019, Palliative short-course radiotherapy in advanced pelvic cancer: a phase II study (SHARON Project), Anticancer Res, 39, 4237, 10.21873/anticanres.13585 Spanos, 1989, Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502, Int J Radiat Oncol Biol Phys, 17, 659, 10.1016/0360-3016(89)90120-X Spanos, 1993, Effect of rest interval on tumor and normal tissue response–a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502), Int J Radiat Oncol Biol Phys, 25, 399, 10.1016/0360-3016(93)90059-5 Yan, 2011, A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients, Clin Oncol, 23, 476, 10.1016/j.clon.2011.01.001 Perry, 2016, A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062–22061, TROG 08.02, NCT00482677), J Clin Oncol, 34, 10.1200/JCO.2016.34.18_suppl.LBA2 Roa, 2004, Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial, J Clin Oncol, 22, 1583, 10.1200/JCO.2004.06.082 Hall, 2017, BC2001 long-term outcomes: a phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer, J Clin Oncol, 35, 10.1200/JCO.2017.35.6_suppl.280 Porta, 2019, Hypo-fractionation in muscle-invasive bladder cancer: an individual patient data (IPD) meta-analysis of the BC2001 and BCON trials, Int J Radiat Oncol Biol Phys, 105, S138, 10.1016/j.ijrobp.2019.06.130 Vaidya, 2016, Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials, Int J Radiat Oncol Biol Phys, 96, 259, 10.1016/j.ijrobp.2016.05.008 Agrawal, 2011, First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015), Radiother Oncol, 100, 93, 10.1016/j.radonc.2011.06.026 Brunt, 2018, FAST phase III RCT of radiotherapy hypofractionation for treatment of early breast cancer: 10-year results (CRUKE/04/015), Int J Radiat Oncol Biol Phys, 102, 1603, 10.1016/j.ijrobp.2018.08.049 Vicini, 2019, Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial, Lancet, 394, 2155, 10.1016/S0140-6736(19)32514-0 Vaidya, 2014, Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial, Lancet, 383, 603, 10.1016/S0140-6736(13)61950-9 Wang, 2019, Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial, Lancet Oncol, 20, 352, 10.1016/S1470-2045(18)30813-1 Sanz, 2018, Once-weekly hypofractionated radiotherapy for breast cancer in elderly patients: efficacy and tolerance in 486 patients, Biomed Res Int, 2018, 8321871, 10.1155/2018/8321871 Yom, 2019, NRG-HN002: a randomized phase II trial for patients with p16-positive, non-smoking-associated, locoregionally advanced oropharyngeal cancer, Int J Radiat Oncol Biol Phys, 105, 684, 10.1016/j.ijrobp.2019.08.038 Lyhne, 2015, The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma, Radiother Oncol, 117, 91, 10.1016/j.radonc.2015.07.004 Overgaard, 2003, Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial, Lancet, 362, 933, 10.1016/S0140-6736(03)14361-9 Singh, 2019, One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial, Int J Radiat Oncol Biol Phys, 105, 752, 10.1016/j.ijrobp.2019.08.019 Videtic, 2019, Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 103, 1077, 10.1016/j.ijrobp.2018.11.051 Videtic, 2015, A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927), Int J Radiat Oncol Biol Phys, 93, 757, 10.1016/j.ijrobp.2015.07.2260 Din, 2013, Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres, Radiother Oncol, 109, 8, 10.1016/j.radonc.2013.07.014 Iqbal, 2019, Hypofractionated concomitant chemoradiation in inoperable locally advanced non-small cell lung cancer: a report on 100 patients and a systematic review, Clin Oncol, 31, e1, 10.1016/j.clon.2018.10.006 Maguire, 2014, SOCCAR: a randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non-small cell lung cancer and good performance status, Eur J Cancer, 50, 2939, 10.1016/j.ejca.2014.07.009 Giuliani, 2015, Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma, Clinical Lung Cancer, 16, 216, 10.1016/j.cllc.2014.11.008 Halvorsen, 2016, Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer, Lung Cancer, 102, 9, 10.1016/j.lungcan.2016.10.003 Koay, 2020, Dose-escalated radiation therapy for pancreatic cancer: a simultaneous integrated boost approach, Pract Radiat Oncol, 10.1016/j.prro.2020.01.012 Oar, 2019, Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT), Pract Radiat Oncol Catton, 2017, Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer, J Clin Oncol, 35, 1884, 10.1200/JCO.2016.71.7397 Staffurth, 2018, Impact of prostate cancer hypofractionation on patient reported outcomes: baseline to 5 years change in the CHHIP trial, Int J Radiat Oncol Biol Phys, 102, S1, 10.1016/j.ijrobp.2018.06.102 Zelefsky, 2019, Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer, Int J Radiat Oncol Biol Phys, 104, 42, 10.1016/j.ijrobp.2018.12.045 S. Chin et al. Ten-year outcomes of moderately hypofractionated salvage postprostatectomy radiation therapy and external validation; contemporary multivariable nomogram for biochemical failure Int J Radiat Oncol Biol Phys. Zhou, 2014, Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis, Surg Oncol, 23, 211, 10.1016/j.suronc.2014.10.003 Tunio, 2012, Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience, Int J Radiat Oncol Biol Phys, 82, e457, 10.1016/j.ijrobp.2011.05.051 Byun, 2019, Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era, Radiat Oncol, 14, 51, 10.1186/s13014-019-1256-6 Wernicke, 2016, Glioblastoma: radiation treatment margins, how small is large enough?, Pract Radiat Oncol, 6, 298, 10.1016/j.prro.2015.12.002 Pisansky, 2015, Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910, J Clin Oncol, 33, 332, 10.1200/JCO.2014.58.0662